The chief executive of UCB SA, Roch Doliveux, has been appointed to the governing board of the Innovative Medicines Initiative, a public-private partnership formed by the European Commission and European Federation of Pharmaceutical Industries and Associations (EFPIA) to foster advanced medical research in Europe.
The Commission contributes €1 billion of the funding which is matched by in-kind donations from EFPIA’s members.
Copyright 2010 Evernow Publishing Ltd